For research use only. Not for use in humans.

Torudokimab (Anti-IL-33)

Synonyms: LY-3375880 Cat.No.A3084 Purity:99%

Torudokimab (Anti-IL-33) is a fully human monoclonal antibody targeting human IL-33. It can be used in research of atopic dermatitis. MW :145.22 KD.

Quality Control

Batch: A308401 Purity: 99% Protein concentration: 9.71mg/ml Endotoxin Level: ＜1EU/mg

Cited in Nature Medicine for its top-tier quality
COA
SDS
Datasheet

Featured Inhibitors	Y-27632 Dihydrochloride SB431542 CHIR-99021 (Laduviglusib) RMC-7977 RMC-6236 (Daraxonrasib) MRTX1133 MG132 Z-VAD-FMK VT3989 IAG933

Specificity

Expand to Check More

1. "+" indicates inhibitory effect. Increased inhibition is marked by a higher "+" designation. 2. "✔" indicates inhibitory effect, but without specific value.

Mechanism of Action

Description	Torudokimab (Anti-IL-33) is a fully human monoclonal antibody targeting human IL-33. It can be used in research of atopic dermatitis. MW :145.22 KD.
References	[1] https://pubmed.ncbi.nlm.nih.gov/34408465/

Cell Lines	Assay Type	Concentration	Incubation Time	Formulation	Activity Description	PMID

Product Details

CAS No.	2241728-76-5
Isotype	Human IgG4SP
Source	CHO
Formulation	100 mM Pro-Ac, 20mM Arg, pH5.0
Storage (From the date of receipt)	Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

^*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.